We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Absology

ABSOLOGY is a medical equipment manufacturer that develops and mass-produces in vitro diagnostic medical devices. ABS... read more Featured Products: More products

Download Mobile App





Absology Showcases Latest Advancements in Medical Diagnostics

By LabMedica International staff writers
Posted on 15 Nov 2023
Print article
Image: Absology is sharing its latest products and services at MEDICA 2023 (Photo courtesy of Absology)
Image: Absology is sharing its latest products and services at MEDICA 2023 (Photo courtesy of Absology)

Absology Co., Ltd. (Gyeonggi-do, Korea) is showcasing its POCT innovations at MEDICA 2023 that empower healthcare providers to deliver rapid, accurate diagnostic information at the patient's bedside. Absology is also highlighting its latest innovations in cardiac markers, infectious diseases, endocrine, urology, metabolism, and inflammation testing for humans and companion animals.

At MEDICA 2023, Absology is highlighting the ABSOL automated fluorescent immunoassay (FIA) analyzer. Designed for POCT near the patient testing device, it provides quantitative results based on immunoassay technology. The Absoludy cartridges utilize microfluidics lateral flow technology where the analyte of interest in the sample forms immune complexes while moving through the pathway in the cartridges. Inside ABSOL Analyzer, a built-in on/off valve system can actively control the flow of specimens to ensure reliable test results.

Absology is also highlighting its groundbreaking approach to Alzheimer's diagnosis with ABSOL HS. The cutting-edge POCT device, developed by ABSOLOGY's expert researchers, utilizes Photo oxidation-induced fluorescence amplification (PIFA) technology for unmatched sensitivity. It can detect Alzheimer's in its early stages, ensuring timely interventions and improved patient outcomes. Plus, ABSOL HS seamlessly integrates into the laboratory workflow, making disease detection hassle-free.

Related Links:
Absology Co., Ltd. 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.